Introduction Dual antiplatelet therapy (DAPT) represents the cornerstone of secondary
prevention in patients presenting with acute coronary syndrome (ACS) and undergoing …

Abstract Purpose of Review The effect of gender on use of dual antiplatelet therapy (DAPT)
in treatment of acute coronary syndrome (ACS) is not well established. The purpose of this …

Dual antiplatelet therapy (DAPT) is the gold standard for the antithrombotic management of
patients with an acute coronary syndrome (ACS) or undergoing percutaneous coronary …

Over the past decade, more men than women have shown improved outcomes from
antithrombotic therapies after acute coronary syndrome (ACS), which raises the question of …

Cardiovascular diseases are the leading causes of mortality, and several medical and non-
medical pillars play a pivotal role in improving prognosis. Inhibition of platelet reactivity in …

Coronary heart disease (CHD) is the leading cause of morbidity and mortality in both men
and women in the developed countries. Despite this fact, females are still under-represented …

Background Although dual antiplatelet therapy (DAPT) improves the outcomes of patients
undergoing percutaneous coronary intervention (PCI), sex-specific differences in efficacy …

Objectives This prespecified analysis of the TROPICAL-ACS trial aimed to assess the impact
of gender on clinical outcomes and platelet reactivity (PR) following guided de-escalation of …

Importance Abbreviated dual antiplatelet therapy (DAPT) reduces bleeding with no increase
in ischemic events in patients at high bleeding risk (HBR) undergoing percutaneous …

Conventional dual antiplatelet therapy (DAPT) for patients with acute coronary syndromes
undergoing percutaneous coronary intervention comprises aspirin with a potent P2Y …